Drug intelligence / Profile preview

fructus aurantii

Development stage
Unknown
Modality
Small Molecules
Administration
Oral
01

Overview

Fructus Aurantii is the dried immature fruit of Citrus aurantium L. (bitter orange) and its cultivars. In traditional Chinese medicine (TCM), it is known as Zhi Ke or Zhi Qiao (枳壳) and is used to promote the movement of Qi, relieve distention and pressure in the abdomen, resolve food stagnation, disperse accumulations, dissolve phlegm, and support gastrointestinal motility[1][2][4]. Pharmacologically, Fructus Aurantii contains flavonoids and other bioactive compounds with anti-inflammatory and antioxidant properties[6][8]. Modern research indicates that extracts of Fructus Aurantii can ameliorate intestinal inflammation by downregulating inflammatory cytokines such as interleukin 1β and tumor necrosis factor-α while upregulating tight junction proteins in the intestinal barrier[6]. It has been shown to improve symptoms in functional dyspepsia models by promoting gastric emptying and intestinal propulsion through modulation of gastrointestinal hormones including motilin, gastrin, ghrelin, vasoactive intestinal peptide (VIP), leptin, calcitonin gene-related peptide (CGRP), and cholecystokinin[7]. The mechanism involves regulation of pathways such as Fc epsilon RI signaling pathway[6]. Clinically it is used for digestive disorders like abdominal distention/constipation/indigestion/functional dyspepsia/irritable bowel syndrome; some evidence also suggests potential benefits for weight management though data are inconclusive[3][8].

Other names
zhi kezhi qiaobitter orangeaurantii fructus枳壳
02

Targets

TNFA (Tumor necrosis factor alpha (soluble))IL1B (Interleukin-1 beta)

Beyond the preview

Go deeper on fructus aurantii.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on fructus aurantii.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call